In late May of last year, Turing Pharmaceuticals, then a little-known drug company, was nearing a deal to acquire Daraprim, a 62-year-old drug that fights a rare but severe parasitic infection.
Democracy Dies in Darkness
How pharma bro Martin Shkreli described his own drug price hike: ‘Almost all of it is profit.’
February 2, 2016 at 11:33 a.m. EST